LLY - Lilly(Eli) & Co
Close
960.02
19.820 2.065%
Share volume: 2,549,154
Last Updated: Fri 30 Aug 2024 10:02:17 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$940.20
19.82
2.11%
Fundamental analysis
71%
Profitability
90%
Dept financing
25%
Liquidity
50%
Performance
70%
Performance
5 Days
0.76%
1 Month
21.66%
3 Months
17.95%
6 Months
27.11%
1 Year
76.37%
2 Year
218.17%
Key data
Stock price
$960.02
DAY RANGE
$940.51 - $961.00
52 WEEK RANGE
$513.12 - $972.53
52 WEEK CHANGE
$0.73
DIVIDEND
$1.30
EX-DIVIDEND DATE
08/15/2024
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: David Ricks
Region: US
Website: https://www.lilly.com/
Employees: 39,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.lilly.com/
Employees: 39,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Recent news